These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21478494)

  • 21. Iris pigmented lesions as a marker of cutaneous melanoma risk: an Australian case-control study.
    Laino AM; Berry EG; Jagirdar K; Lee KJ; Duffy DL; Soyer HP; Sturm RA
    Br J Dermatol; 2018 May; 178(5):1119-1127. PubMed ID: 29315480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival.
    Chen K; Liu H; Liu Z; Bloomer W; Amos CI; Lee JE; Li X; Nan H; Wei Q
    Mol Carcinog; 2019 Nov; 58(11):2091-2103. PubMed ID: 31435991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
    Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
    Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No Evidence for BRAF as a melanoma/nevus susceptibility gene.
    Jackson S; Harland M; Turner F; Taylor C; Chambers PA; Randerson-Moor J; Swerdlow AJ; dos Santos Silva I; Beswick S; Bishop DT; Newton Bishop JA
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):913-8. PubMed ID: 15824163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
    Takata M; Murata H; Saida T
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Interplay between Nevi and Melanoma Predisposition Unravels Nevi-Related and Nevi-Resistant Familial Melanoma.
    Pellegrini S; Elefanti L; Dall'Olmo L; Menin C
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a functional polymorphism within the 3'-untranslated region of denticleless E3 ubiquitin protein ligase homolog associated with survival in acral melanoma.
    Yang L; Dai J; Ma M; Mao L; Si L; Cui C; Sheng X; Chi Z; Yu S; Xu T; Yu J; Kong Y; Guo J
    Eur J Cancer; 2019 Sep; 118():70-81. PubMed ID: 31325875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
    Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
    Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide association study identifies three new melanoma susceptibility loci.
    Barrett JH; Iles MM; Harland M; Taylor JC; Aitken JF; Andresen PA; Akslen LA; Armstrong BK; Avril MF; Azizi E; Bakker B; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Cannon-Albright LA; Corda E; Cust AE; Dębniak T; Duffy D; Dunning AM; Easton DF; Friedman E; Galan P; Ghiorzo P; Giles GG; Hansson J; Hocevar M; Höiom V; Hopper JL; Ingvar C; Janssen B; Jenkins MA; Jönsson G; Kefford RF; Landi G; Landi MT; Lang J; Lubiński J; Mackie R; Malvehy J; Martin NG; Molven A; Montgomery GW; van Nieuwpoort FA; Novakovic S; Olsson H; Pastorino L; Puig S; Puig-Butille JA; Randerson-Moor J; Snowden H; Tuominen R; Van Belle P; van der Stoep N; Whiteman DC; Zelenika D; Han J; Fang S; Lee JE; Wei Q; Lathrop GM; Gillanders EM; Brown KM; Goldstein AM; Kanetsky PA; Mann GJ; Macgregor S; Elder DE; Amos CI; Hayward NK; Gruis NA; Demenais F; Bishop JA; Bishop DT;
    Nat Genet; 2011 Oct; 43(11):1108-13. PubMed ID: 21983787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.
    Sand M; Skrygan M; Georgas D; Sand D; Gambichler T; Altmeyer P; Bechara FG
    Cell Tissue Res; 2012 Oct; 350(1):119-26. PubMed ID: 22706980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
    Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
    Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk.
    Llorca-Cardeñosa MJ; Peña-Chilet M; Mayor M; Gomez-Fernandez C; Casado B; Martin-Gonzalez M; Carretero G; Lluch A; Martinez-Cadenas C; Ibarrola-Villava M; Ribas G
    Eur J Cancer; 2014 Dec; 50(18):3168-77. PubMed ID: 25457634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A search for CDKN2A/p16INK4a mutations in melanocytic nevi from patients with melanoma and spouse controls by use of laser-captured microdissection.
    Wang H; Presland RB; Piepkorn M
    Arch Dermatol; 2005 Feb; 141(2):177-80. PubMed ID: 15724013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin.
    Gerami P; Alsobrook JP; Palmer TJ; Robin HS
    J Am Acad Dermatol; 2014 Aug; 71(2):237-44. PubMed ID: 24906614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
    Chaudru V; Chompret A; Bressac-de Paillerets B; Spatz A; Avril MF; Demenais F
    J Natl Cancer Inst; 2004 May; 96(10):785-95. PubMed ID: 15150307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the interplay of telomeres, nevi and the risk of melanoma.
    Bodelon C; Pfeiffer RM; Bollati V; Debbache J; Calista D; Ghiorzo P; Fargnoli MC; Bianchi-Scarra G; Peris K; Hoxha M; Hutchinson A; Burdette L; Burke L; Fang S; Tucker MA; Goldstein AM; Lee JE; Wei Q; Savage SA; Yang XR; Amos C; Landi MT
    PLoS One; 2012; 7(12):e52466. PubMed ID: 23300679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas.
    Bastian BC; Xiong J; Frieden IJ; Williams ML; Chou P; Busam K; Pinkel D; LeBoit PE
    Am J Pathol; 2002 Oct; 161(4):1163-9. PubMed ID: 12368190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melanocytic nevi and tumor progression: perspectives concerning histomorphology, melanoma risk and molecular genetics.
    Barnhill RL
    Dermatology; 1993; 187(2):86-90. PubMed ID: 8358111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J; Cronin F; Duncan LM
    Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunohistochemical analysis of ras gene expression in human melanomas and melanocytic nevi].
    Yasuda H
    Hokkaido Igaku Zasshi; 1989 May; 64(3):243-53. PubMed ID: 2670726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.